Research on the preferences of patients with AD, caregivers, and health care providers may be influenced by pharmaceutical company sponsorship.

The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

By including information on suicidal thoughts and behaviors, clinicians can greatly improve predictive accuracy via machine learning.

Metabolic and bariatric surgery may improve patients' self-esteem and decrease their internalized weight stigma.

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Certain pain-related pruritus descriptors may independently predict mental health outcomes, sleep disturbance, and QOL reduction in patients with AD.

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

Caregivers for people with dementia are more likely to report having at least one modifiable risk factor linked to developing dementia.